Researchers have found in a new study that the hemoglobin, albumin, lymphocyte, and platelet score serves as an independent predictor of 30-day readmission in patients with acute exacerbation ...

Iovance Biotherapeutics (NASDAQ:IOVA) gains attention in the Nasdaq Index as biotech sentiment and allocation trends shift.

Objective This research aimed to determine the feasibility and accuracy of CLR and clinical features to formulate a prediction model for Peptic Ulcer (PU)-induced Upper Gastrointestinal Bleeding (UGIB ...

Mary J. Scourboutakos does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

UK rental company Reactive Rentals filed for liquidation just before midnight yesterday. The company directors, Steve Skeates and Gary Sprecht, instructed FTS Recovery at the end of September to ...

Background: While the novel C-reactive protein-albumin-lymphocyte (CALLY) index—integrating inflammatory, nutritional, and immune markers—has proven valuable for prognosis in various diseases, its ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

It hasn’t been that long since humans figured out how to create power grids that integrated multiple generators and consumers. Ever since AC won the battle of the currents, grid operators have had to ...

Vaccination efforts worldwide have drastically diminished morbidity and mortality rates for many infectious diseases, with some pathogens being entirely eradicated. However, to optimize long-term ...

A NEW study has found that a simple blood-based biomarker, known as the C-reactive protein-albumin-lymphocyte (CALLY) index, may provide important prognostic information for patients with rheumatoid ...

Two key poster presentations to highlight cTRLs as a novel cell type well-equipped to overcome the challenges of traditional cell therapies in solid tumors, like colorectal cancer and melanoma cTRL's ...

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a clinical-stage biotechnology company developing a differentiated approach to ...